LLABS deploys enterprise agents into bounded roles. They work in your systems and improve from outcomes through Causal Trajectory Learning.
Levangie Laboratories, Inc. has raised $4.5M in total funding. The most recent round was Seed. The last funding was announced in August 2026.
Levangie Laboratories, Inc.'s investors include Overline, Tech Square Ventures, Tandem Ventures, SaaS Ventures.
Levangie Laboratories, Inc. is headquartered in San Francisco, United States.
LLABS deploys enterprise agents into bounded roles. They work in your systems and improve from outcomes through Causal Trajectory Learning.
Levangie Laboratories, Inc. is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Levangie Laboratories, Inc. — Funding & Investors." VCBacked, August 5, 2026, https://www.vcbacked.co/company/levangie-laboratories-inc. Accessed September 4, 2026.
VCBacked. (2026). Levangie Laboratories, Inc. — Funding & Investors. Retrieved September 4, 2026, from https://www.vcbacked.co/company/levangie-laboratories-inc
{{cite web |title=Levangie Laboratories, Inc. — Funding & Investors |url=https://www.vcbacked.co/company/levangie-laboratories-inc |website=VCBacked |access-date=September 4, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated